Government / Government Watch / Health & Medical / Health Wellness / Health, Policy & Regulation / Mental Health / Public Health
The Adderall Shortage Isn’t an Accident—It’s a Policy Failure
The ongoing Adderall shortage, affecting Americans with ADHD since late 2022, results from regulatory failures and mismatched supply and demand. Rising ADHD diagnoses, increased telehealth access, and reduced stigma highlighted the need for flexible production quotas. Patients face significant disruptions, impacting their performance and well-being, while effective governance remains elusive.